Member Info for bignose58

The.Italian,

Certainly all a bit strange. 2 days ago 20mill buys and 10mill sells with a few large buys it only managed to end up just over 4 % (ok it did peak at about 17%), yet, yesterday and today with only a few 10k and it drops by about 4%, although finishing flat. Certainly feels like some manipulation is going on. It would appear its being kept in a close range of 0.09hkd ?

As the Italian pointed out. This is similar to what has happened over the last few weeks. A slow decline and then pop a sudden buying spree. Given how it has been pretty lackluster over the last 12 months, it does feel like something is going on. And apparently JG is quite adamant that the 20 months or so for the FDA to review the NDA submission is no mistake, although I don't quite know what to make of that since as far as I am aware it takes between 6 to 12 months to make the approval (he did state that any change in timeline would be advised if and when necessary - maybe he is just hedging his bets given the terrible performance the company has had on meeting any form of announced deadline since I don't know when..... He has probably now totally lost contact with any form of reality.....lol

Interesting to see what volumes there are tomorrow.

C82,

I think you are getting beyond yourself there. Any licensee wanting to buy any large amounts to offset outlay would be picked up one way or another even if they didn't declare to the HKSE, which given all the recent news on new laws etc one would surely think twice about doing at the moment.

The.Italian,

I was watching it through the day. By lunchtime when trading had ceased, there were 15.2m buys above 0.96 with only 3.4mill sells above. Both averages were larger than 0.1, yet the sp was at 0.092. Average price for all 30mill shares at lunchtime was 0.097 (as shown on the system). Something very strange going on for an automated matching sell/buy system.

Obviously the system is suffering from JG syndrome (JGS).....lol

The.Italian.

We may have a product, but unfortunately the men at the top have wasted the early opportunity. Just think where we would be if both the EU and US had used the 20 dose can in the first place. I am not suggesting sales would have been any different in the EU, but we would be where we are now 2 years ago and then launching with a variation and 12 dose canister. Unfortunately the company was driven by too much greed (money fountain and all that), like all of us... :-). The only difference is; none of us keeps getting paid for our mistakes....... LOL

The.Italian

It had a market cap fluctuating between 4 and 6 mill GBP, so it has done quite well in the short term. Going by the RNS it looks like it could go up a few times more come Sept and if the results of the internal third stage pre in vivo study are positive. Unfortunately I didn't have any free cash to throw at it as I was waiting for funds to come liquid and available, which have been delayed. Mind you, there is still time to invest since you know as well as me how fickle the markets are and how quickly an SP can rise and fall on sentiments alone with no real logic behind price movements. especially for low cap companies currently like this one. This will surely fly on the shirt tails of C-19 with a possible mkt cap of 200mill (this is based on nothing more than achievements I have witnessed by other companies mentioning links to C-19).

A bit like here. We are bouncing around near the bottom, which, looking at price movements compared to volumes (1m buy and no movement yet 10k buy or sell can move the SP 3 to 5%)...is again showing no logic whatsoever. I'm sure once news of the Phase II completion is announced, we could see this back near the 0.3 mark and if a US licensee commits, the doors could fly open with no prisoners taken. Just my opinion based on how significant the drop has been with no positive news at hand. Hopefully the change in HK market status wont effect it too much. It could even be positive if it opens the doors to mainland investors, which have been kept under lock and key. (Very difficult for a mainland pi investor to buy on the HK stock market without some jiggery-pokery to open an investment account etc in HK.

So we wait and see if incompetence once again raises its ugly head to knock us back down again....lol.

The.Italian
Too true. How on earth do they know sales will increase if they have done no market research.....or have they ? Surely they won’t be caught with their trousers down twice ? They gave all the same carp about upping production in preparation for the initial launch which we now know was just pie in the sky.

Dougie,
I’m only going by what has been stated in the updates and in the content of emails received by me, although I’m sure the fact that the EU OTC approval, which appears to now be just a formality, has provided some added confidence, however. I can only speculate that the company must have discussed starting phase III before the end of phase II with the FDA otherwise they surely wouldn’t be contemplating it. That said, I do understand the company has been in constant dialogue with the FDA over the years where it surely must have been tabled ?

At the end of the day, the proof will be in the pudding or in this case, the signing :-)

The.Italian/Kieth,
I also get the impression that if an agreement is signed with a strategic partner/s for the US market it will also unlock the possibility of agreements for the Middle East and Latin American regions since they seem to value the FDA approval process, which could occur anytime between now and this time next year. Just my opinion from the recent updates.

Its just out....

http://www.regentpac.com/ICMServlet/download/13-2355-3816/EAnnt-ProfitWarning(07Aug2020).pdf

Keith,
I think it will be sooner than that. It may take 3 to 4 years to achieve significant sales in the US, but then it depends what each of us considers as our end game?
The SP will have risen significantly (IMHO) long before then, based on a license agreement being signed and final FDA approval about the end of next year.
Of course if one is to include China in ones end game, then I agree 3 to 4 years, but who will be waiting for China before selling a few at a significant profit ?

This will all come to fruition as long as there are no further ****ups and incompetent delays.
AIMO.... ;-)

Ill believe this when I see it....... but still positive in the right direction

Recordati, PSNW and the Group are looking into options at scaling up the manufacturing process
to meet the anticipated demand in OTC with the aim of manufacturing approximately 50,000 units
per batch order and reducing the risk of supply chain shortage and unreliability.

Still no mention of if the manufacturing problems have been solved.

Read all about it, Read all about it. Operations update........

http://www.regentpac.com/ICMServlet/download/13-2354-3814/EAnnt-OperationsUpdate(05Aug2020).pdf

Dougie, certainly right there. And as usual the Sun's article, like all their articles, is rubbish. They mention the UK, yet wales, Scotland and Northern Ireland have no sufferers....Seems they don't know the difference between the UK and England. I wonder if they actually know what Brexit is.......LOL

It may not be spelt the same, but could be confusing when spoken about. Although they both could influence blood sugar levels .... lol
https://en.m.wikipedia.org/wiki/Milo_(chocolate_bar)

Interestingly Recordati appear to be still doing well even with the current environment. Hopefully they can pull a huge rabbit out of the hat with the switch to OTC.

Ok, maybe I'm jumping the gun here since this now reads as if it was a couple of months ago....we will see

So once again we, as shareholders, have been fed BS.

It MAY be rolled out in other European countries over the coming years. they forgot to add "But probably not".

And this one, which was only verified a week or two ago as "RPG taking the risk to start phase III early".... is now "commencing Phase III work in the latter half of 2021"

It is just one continuous flow of lies, deception and BS..........

My understanding is (horses mouth n all that) that RPG are going to take the risk and start phase III before the phase II readouts, however. The start date all depends if they have recruited all the phase II participants and sorted papereork as stated in the announcement. So any time after the 1st August. (Think that was the date given as recruiting timeline). I'm sure the update will include all this be it good or bad news.

Hopefully the operational update will include something along the lines of "all phase II subjects have been recruited, we are now progressing with phase III. And because the EU has approved for a switch to OTC, the FDA only requires 1 subject which will now be completed within a week"...... LOL .... I wish...... ;-)